Peptide-based Cancer Therapeutics Market

Peptide-based Cancer Therapeutics Market is segmented by Class (Peptide Hormone Analogues, Peptide Drug Conjugates, Vaccines and Others), Indication (Prostate and Breast, Neuroendocrine and Gastrointestinal, Melanoma and Others), Line of Therapy (2L and 3L, 1L, Adjuvant and Others), and Region, with forecasts covering the period from 2026 to 2036.